- Home
- FRAF vs KOD Comparison
FRAF vs KOD Comparison
Compare FRAF & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRAF | KOD |
|---|---|---|
| Founded | 1906 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 206.3M | 795.5M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | FRAF | KOD |
|---|---|---|
| Price | $51.03 | $29.89 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $22.67 |
| AVG Volume (30 Days) | 58.2K | ★ 929.1K |
| Earning Date | 01-27-2026 | 11-13-2025 |
| Dividend Yield | ★ 2.59% | N/A |
| EPS Growth | ★ 9.43 | N/A |
| EPS | ★ 3.50 | N/A |
| Revenue | ★ $77,783,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $14.57 | ★ N/A |
| Revenue Growth | ★ 8.75 | N/A |
| 52 Week Low | $28.01 | $1.92 |
| 52 Week High | $59.95 | $31.18 |
Technical Indicators
Market Signals| Indicator | FRAF | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 42.43 | 67.09 |
| Support Level | $55.61 | $25.44 |
| Resistance Level | $57.51 | $31.18 |
| Average True Range (ATR) | 1.41 | 2.23 |
| MACD | -0.68 | 0.38 |
| Stochastic Oscillator | 9.72 | 86.73 |
Price Performance
Historical ComparisonAbout FRAF Franklin Financial Services Corporation
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.